380 related articles for article (PubMed ID: 28257315)
1. Personalized medicine and chronic obstructive pulmonary disease.
Wouters EF; Wouters BB; Augustin IM; Franssen FM
Curr Opin Pulm Med; 2017 May; 23(3):241-246. PubMed ID: 28257315
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of chronic obstructive pulmonary disease.
Hersh CP
Expert Rev Respir Med; 2019 May; 13(5):459-470. PubMed ID: 30925849
[TBL] [Abstract][Full Text] [Related]
3. An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?
Cazzola M; Rogliani P; Puxeddu E; Ora J; Matera MG
Expert Rev Respir Med; 2018 Jan; 12(1):43-54. PubMed ID: 29082808
[TBL] [Abstract][Full Text] [Related]
4. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.
Woodruff PG; Agusti A; Roche N; Singh D; Martinez FJ
Lancet; 2015 May; 385(9979):1789-1798. PubMed ID: 25943943
[TBL] [Abstract][Full Text] [Related]
5. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
Singh D; Roche N; Halpin D; Agusti A; Wedzicha JA; Martinez FJ
Am J Respir Crit Care Med; 2016 Sep; 194(5):541-9. PubMed ID: 27585383
[TBL] [Abstract][Full Text] [Related]
6. What does endotyping mean for treatment in chronic obstructive pulmonary disease?
Agustí A; Celli B; Faner R
Lancet; 2017 Sep; 390(10098):980-987. PubMed ID: 28872030
[TBL] [Abstract][Full Text] [Related]
7. Personalized medicine for patients with COPD: where are we?
Franssen FM; Alter P; Bar N; Benedikter BJ; Iurato S; Maier D; Maxheim M; Roessler FK; Spruit MA; Vogelmeier CF; Wouters EF; Schmeck B
Int J Chron Obstruct Pulmon Dis; 2019; 14():1465-1484. PubMed ID: 31371934
[TBL] [Abstract][Full Text] [Related]
8. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
Campos MA; Lascano J
Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
[TBL] [Abstract][Full Text] [Related]
9. "Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.".
Corlateanu A; Mendez Y; Wang Y; Garnica RJA; Botnaru V; Siafakas N
Pulmonology; 2020; 26(2):95-100. PubMed ID: 31740261
[TBL] [Abstract][Full Text] [Related]
10. Targeting Chronic Obstructive Pulmonary Disease Phenotypes, Endotypes, and Biomarkers.
Garudadri S; Woodruff PG
Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S234-S238. PubMed ID: 30758998
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine in chronic obstructive pulmonary disease: how far have we come?
Khan MMKS; Cole AG; Mannino DM
Curr Opin Pulm Med; 2022 Mar; 28(2):115-120. PubMed ID: 34652296
[TBL] [Abstract][Full Text] [Related]
12. [Developing Biomarkers in Precision Medicine for Asthma and COPD].
Hirai K
Yakugaku Zasshi; 2023; 143(3):249-255. PubMed ID: 36858558
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine.
Brandsma CA; Van den Berge M; Hackett TL; Brusselle G; Timens W
J Pathol; 2020 Apr; 250(5):624-635. PubMed ID: 31691283
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers, the control panel and personalized COPD medicine.
Agusti A; Gea J; Faner R
Respirology; 2016 Jan; 21(1):24-33. PubMed ID: 26172306
[TBL] [Abstract][Full Text] [Related]
15. Vaccination and modern management of chronic obstructive pulmonary disease - a narrative review.
Joean O; Welte T
Expert Rev Respir Med; 2022 Jun; 16(6):605-614. PubMed ID: 35713962
[TBL] [Abstract][Full Text] [Related]
16. Clinical Drug Development Using Dynamic Biomarkers to Enable Personalized Health Care in COPD.
Bihlet AR; Karsdal MA; Bay-Jensen AC; Read S; Kristensen JH; Sand JMB; Leeming DJ; Andersen JR; Lange P; Vestbo J
Chest; 2015 Jul; 148(1):16-23. PubMed ID: 25856563
[TBL] [Abstract][Full Text] [Related]
17. The Challenges of Precision Medicine in COPD.
Cazzola M; Calzetta L; Rogliani P; Matera MG
Mol Diagn Ther; 2017 Aug; 21(4):345-355. PubMed ID: 28247183
[TBL] [Abstract][Full Text] [Related]
18. [Expert Meeting on COPD: Personalized Treatment of COPD - Wishful Thinking or Reality?].
Lorenz J; Bals R; Ewert R; Jany B; Koczulla AR; Köhnlein T; Randerath WJ; Steinkamp G; Watz H; Welte T
Pneumologie; 2016 Oct; 70(10):638-650. PubMed ID: 27723914
[TBL] [Abstract][Full Text] [Related]
19. Introduction to precision medicine in COPD.
Leung JM; Obeidat M; Sadatsafavi M; Sin DD
Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30679189
[TBL] [Abstract][Full Text] [Related]
20. [PERSONALIZED MEDICINE: CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATMENT].
Corhay JL
Rev Med Liege; 2015; 70(5-6):310-5. PubMed ID: 26285458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
